Verastem, Inc. (VSTM)
8.44
-0.65
(-7.15%)
USD |
NASDAQ |
Nov 12, 16:00
8.60
+0.16
(+1.90%)
After-Hours: 05:32
Verastem Free Cash Flow (Quarterly) : -41.09M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -41.09M |
| June 30, 2026 | -43.91M |
| March 31, 2026 | -52.12M |
| December 31, 2025 | -31.30M |
| September 30, 2025 | -44.50M |
| June 30, 2025 | -32.66M |
| March 31, 2025 | -38.68M |
| December 31, 2024 | -25.10M |
| September 30, 2024 | -23.80M |
| June 30, 2024 | -27.58M |
| March 31, 2024 | -28.33M |
| December 31, 2023 | -29.68M |
| September 30, 2023 | -16.59M |
| June 30, 2023 | -19.90M |
| March 31, 2023 | -20.29M |
| December 31, 2022 | -16.62M |
| September 30, 2022 | -15.08M |
| June 30, 2022 | -12.69M |
| March 31, 2022 | -19.28M |
| December 31, 2021 | -9.933M |
| September 30, 2021 | -10.83M |
| June 30, 2021 | -13.42M |
| March 31, 2021 | -19.51M |
| December 31, 2020 | -21.70M |
| September 30, 2020 | 42.98M |
| Date | Value |
|---|---|
| June 30, 2020 | -22.57M |
| March 31, 2020 | -34.00M |
| December 31, 2019 | -37.66M |
| September 30, 2019 | -27.86M |
| June 30, 2019 | -34.67M |
| March 31, 2019 | -38.78M |
| December 31, 2018 | -19.45M |
| September 30, 2018 | -23.13M |
| June 30, 2018 | -10.89M |
| March 31, 2018 | -22.56M |
| December 31, 2017 | -20.33M |
| September 30, 2017 | -11.85M |
| June 30, 2017 | -14.48M |
| March 31, 2017 | -10.65M |
| December 31, 2016 | -5.952M |
| September 30, 2016 | -6.058M |
| June 30, 2016 | -6.691M |
| March 31, 2016 | -10.82M |
| December 31, 2015 | -10.21M |
| September 30, 2015 | -11.62M |
| June 30, 2015 | -12.02M |
| March 31, 2015 | -11.92M |
| December 31, 2014 | -10.22M |
| September 30, 2014 | -10.70M |
| June 30, 2014 | -9.118M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Cytokinetics, Inc. | -124.72M |
| Inovio Pharmaceuticals, Inc. | -15.27M |
| Rigel Pharmaceuticals, Inc. | 34.35M |
| United Therapeutics Corp. | 125.80M |
| SELLAS Life Sciences Group, Inc. | -7.588M |